These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16390322)

  • 1. Mechanisms and mediators of pulmonary fibrosis.
    Keane MP; Strieter RM; Belperio JA
    Crit Rev Immunol; 2005; 25(6):429-63. PubMed ID: 16390322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of pulmonary fibrosis and current treatment.
    Kuwano K; Hagimoto N; Hara N
    Curr Mol Med; 2001 Nov; 1(5):551-73. PubMed ID: 11899231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytokines of pulmonary fibrosis: Much learned, much more to learn.
    Luzina IG; Todd NW; Sundararajan S; Atamas SP
    Cytokine; 2015 Jul; 74(1):88-100. PubMed ID: 25543535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of apoptosis in pulmonary fibrosis.
    Kuwano K; Hagimoto N; Nakanishi Y
    Histol Histopathol; 2004 Jul; 19(3):867-81. PubMed ID: 15168350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specialized pro-resolving mediators in renal fibrosis.
    Brennan EP; Cacace A; Godson C
    Mol Aspects Med; 2017 Dec; 58():102-113. PubMed ID: 28479307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of cytokines and growth factors in fibroproliferative lung disease].
    Kolb M; Schmidt M
    Pneumologie; 2003 Feb; 57(2):91-7. PubMed ID: 12579464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3K/Akt signaling is involved in the pathogenesis of bleomycin‑induced pulmonary fibrosis via regulation of epithelial‑mesenchymal transition.
    Zhang XL; Xing RG; Chen L; Liu CR; Miao ZG
    Mol Med Rep; 2016 Dec; 14(6):5699-5706. PubMed ID: 27878273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Growth factors in the process of inflammation and fibrosis in the lung].
    Matsuse T
    Nihon Kokyuki Gakkai Zasshi; 1998 May; 36(5):413-20. PubMed ID: 9742856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Back to the future: historical perspective on the pathogenesis of idiopathic pulmonary fibrosis.
    Noble PW; Homer RJ
    Am J Respir Cell Mol Biol; 2005 Aug; 33(2):113-20. PubMed ID: 16024580
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrating mechanisms of pulmonary fibrosis.
    Wynn TA
    J Exp Med; 2011 Jul; 208(7):1339-50. PubMed ID: 21727191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and angiogenesis in fibrotic lung disease.
    Keane MP; Strieter RM; Lynch JP; Belperio JA
    Semin Respir Crit Care Med; 2006 Dec; 27(6):589-99. PubMed ID: 17195136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis.
    Gharaee-Kermani M; Phan SH
    Curr Pharm Des; 2005; 11(30):3943-71. PubMed ID: 16305523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased asbestos-induced lung inflammation and fibrosis after radiation and bone marrow transplant.
    Levis J; Loi R; Butnor KJ; Vacek P; Steele C; Mossman BT; Weiss DJ
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):16-25. PubMed ID: 17673685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of bone marrow mesenchymal stem cells in the development of PQ‑induced pulmonary fibrosis.
    Chen J; Si L; Zhou L; Deng Y
    Mol Med Rep; 2019 Apr; 19(4):3283-3290. PubMed ID: 30816470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of pulmonary fibrosis: is there a fibrosis gene?
    Marshall RP; McAnulty RJ; Laurent GJ
    Int J Biochem Cell Biol; 1997 Jan; 29(1):107-20. PubMed ID: 9076945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble TNF mediates the transition from pulmonary inflammation to fibrosis.
    Oikonomou N; Harokopos V; Zalevsky J; Valavanis C; Kotanidou A; Szymkowski DE; Kollias G; Aidinis V
    PLoS One; 2006 Dec; 1(1):e108. PubMed ID: 17205112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.
    Selman M; King TE; Pardo A; ; ;
    Ann Intern Med; 2001 Jan; 134(2):136-51. PubMed ID: 11177318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipids and eicosanoids in fibrosis: emerging targets for therapy.
    Castelino FV
    Curr Opin Rheumatol; 2012 Nov; 24(6):649-55. PubMed ID: 22810365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice.
    Tanaka K; Tanaka Y; Namba T; Azuma A; Mizushima T
    Biochem Pharmacol; 2010 Sep; 80(6):920-31. PubMed ID: 20513440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines and inflammatory mediators in cystic fibrosis.
    Courtney JM; Ennis M; Elborn JS
    J Cyst Fibros; 2004 Dec; 3(4):223-31. PubMed ID: 15698939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.